Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Neuroinflammation is increasingly recognized as a hallmark of neurodegeneration. Activated central nervous system–resident microglia and infiltrating immune cells contribute to the degeneration of dopaminergic neurons (DNs). However, how the inflammatory process leads to neuron loss and whether blocking this response would be beneficial to disease progression remains largely unknown. CD95 is a mediator of inflammation that has also been proposed as an apoptosis inducer in DNs, but previous studies using ubiquitous deletion of CD95 or CD95L in mouse models of neurodegeneration have generated conflicting results. Here we examine the role of CD95 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin (MPTP)–induced neurodegeneration using tissue-specific deletion of CD95 or CD95L. We show that DN death is not mediated by CD95-induced apoptosis because deletion of CD95 in DNs does not influence MPTP-induced neurodegeneration. In contrast, deletion of CD95L in peripheral myeloid cells significantly protects against MPTP neurotoxicity and preserves striatal dopamine levels. Systemic pharmacological inhibition of CD95L dampens the peripheral innate response, reduces the accumulation of infiltrating myeloid cells, and efficiently prevents MPTP-induced DN death. Altogether, this study emphasizes the role of the peripheral innate immune response in neurodegeneration and identifies CD95 as potential pharmacological target for neurodegenerative disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. Pharmacological neutralization of CD95L protects mice against MPTP toxicity and alters peripheral immune response. (A) Scheme of MPTP and APG112 treatment. (B) Quantification of total TH+ DNs in the SNpc at day 6 after last administration of saline or MPTP of control or APG112-treated mice. ANOVA followed by Newman–Keuls post-hoc test: control versus MPTP: *, P < 0.001; MPTP versus MPTP + APG112: †, P < 0.01. (C) Representative images of TH+ neurons in SNpc of control and APG112-treated mice. Bar, 100 µm. (D) Quantification of striatal DA levels using HPLC at day 6 after last administration of saline or MPTP to control or APG112-treated mice. (E) Calculation of the metabolite ratio [(DOPAC + HVA/DA) × 100] after quantification of striatal DA metabolite levels by HPLC. (D and E) Data are presented as mean ± SEM; n = 8. ANOVA on ranks, Student–Newman–Keuls multiple comparison: *, P < 0.05; **, P < 0.01; ***, P < 0.001. (F) HPLC measurement of striatal MPP+ levels in WT and WT + APG112 mice at 90 min after MPTP injection. Data are presented as mean ± SEM; n = 3. Student’s t test: n.s., not significant. (G) Representative dot plots of blood monocytes and gating scheme of flow cytometry. (H) Quantification of blood monocyte subsets by FACS at day 6 after last administration of saline or MPTP of control or APG112-treated mice. ANOVA followed by Newman–Keuls post-hoc test: *, P < 0.05. (B and H) Data are presented as dot plot with median and were pooled from two independent experiments; n = 16–17.](https://figures.cochat.ai/paper-figures/bb2d2197122447e48d9a6f017bfdc066/infiltration-of-circulating-myeloid-cells-through-cd95l-contributes-to-figure-3.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“sialoadhesin (SIGLEC1; also known as CD169) is a marker for mature dendritic cells and macrophages in both mice and humans48 and has been proposed as a marker for invading monocyte-derived macrophages in the CNS as it is not expressed in microglia in health or disease49–52.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175 · cited 1×
“Recent studies show conclusively that adult microglia derive from yolk sac myeloid progenitors at E8 and are distinct from monocyte-derived macrophages (Ginhoux et al., 2010; Schulz et al., 2012; Kierdorf et al., 2013a).”
Calamita, E., Schmid, M., Kunz, M., Ndebele-Murisa, M. R., Magadza, C. H. D., Nyambe, I., & Wehrli, B. (2019) · Figshare · doi:10.26181/6153922fe919c · Cited by 4,222
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
Self-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542 · cited 1×
“Expression of P2Y12, a metabotropic purinergic receptor, was observed in central microglia but not in peripheral myeloid cells (Haynes et al., 2006).”
BackgroundMicroglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E. G., Wieghofer, P., Heinrich, A., Riemke, P., Hölscher, C., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3318 · Cited by 1,457
Self-citationHuman CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors
Cros, J., Cagnard, N., Woollard, K., Patey, N., Zhang, S.-Y., Senechal, B., Puel, A., Biswas, S. K., Moshous, D., Picard, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.012 · Cited by 1,249
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 1×
“Microglial activation and release of proinflammatory factors have been clearly associated with degeneration of SNpc DNs (Liberatore et al., 1999; Wu et al., 2002).”
Background
Cited by
Microglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046
Valdearcos, M., Douglass, J. D., Robblee, M. M., Dorfman, M. D., Stifler, D. R., Bennett, M. L., Gerritse, I., Fasnacht, R., Barres, B. A., Thaler, J. P., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.015 · Cited by 477
“Consistent with this hypothesis, HFD-fed mice had a significant rise in MBH cells expressing CD169 (Siglec1), which marks monocyte-derived cells, but not resident microglia (Butovsky et al., 2012; Gao et al., 2015) (Figures 3E and 3F).”
InfluentialLee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J. M., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 361
Rice, R. A., Spangenberg, E. E., Yamate-Morgan, H., Lee, R. J., Arora, R. P. S., Hernandez, M. X., Tenner, A. J., West, B. L., & Green, K. N. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0336-15.2015 · Cited by 270
Gu, N., Peng, J., Murugan, M., Wang, X., Eyo, U. B., Sun, D., Ren, Y., DiCicco-Bloom, E., Young, W., Dong, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.018 · Cited by 212
“Next, we studied monocyte infiltration after SNT by performing immunohistochemistry for CD169, a well-known marker for macrophages (Gao et al., 2015) in WT mice.”
Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes
Bliederhaeuser, C., Grozdanov, V., Speidel, A., Zondler, L., Ruf, W. P., Bayer, H., Kiechle, M., Feiler, M. S., Freischmidt, A., Brenner, D., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1504-2 · Cited by 180
Self-citationLi, M., Li, Z., Ren, H., Jin, W.-N., Wood, K., Liu, Q., Sheth, K. N., & Shi, F.-D. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16666551 · Cited by 157
Peripheral monocytes are functionally altered and invade the CNS in ALS patients
Zondler, L., Müller, K., Khalaji, S., Bliederhäuser, C., Ruf, W. P., Grozdanov, V., Thiemann, M., Fundel-Clemes, K., Freischmidt, A., Holzmann, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1548-y · Cited by 154
“Our study shows that in contrast to models of PD [25, 28], the infiltration of peripheral monocytes to the CNS of”
BackgroundResultSelf-citationThe contribution of the peripheral immune system to neurodegeneration
Berriat, F., Lobsiger, C. S., & Boillée, S. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01323-6 · Cited by 87
Süß, P., Hoffmann, A., Rothe, T., Ouyang, Z., Baum, W., Staszewski, O., Schett, G., Prinz, M., Krönke, G., Glass, C. K., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.109 · Cited by 85
Self-citationHenning, L., Antony, H., Breuer, A., Müller, J., Seifert, G., Audinat, É., Singh, P., Brosseron, F., Heneka, M. T., Steinhäuser, C., et al. (2022) · Glia · doi:10.1002/glia.24265 · Cited by 73
Parillaud, V. R., Lornet, G., Monnet, Y., Privat, A.-L., Haddad, A. T., Brochard, V., Bekaert, A., de Chanville, C. B., Hirsch, E. C., Combadière, C., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0830-9 · Cited by 70
Role of the IL-1 Pathway in Dopaminergic Neurodegeneration and Decreased Voluntary Movement
Stojakovic, A., Paz-Filho, G., Arcos-Burgos, M., Licinio, J., Wong, M.-L., & Mastronardi, C. A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9988-x · Cited by 64
Genetic manipulation of microglia during brain development and disease
Wieghofer, P., & Prinz, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.019 · Cited by 61
Self-citationA monocyte gene expression signature in the early clinical course of Parkinson’s disease
Schlachetzki, J. C. M., Prots, I., Tao, J., Chun, H. B., Saijo, K., Gosselin, D., Winner, B., Glass, C. K., & Winkler, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-28986-7 · Cited by 56
Valdearcos, M., Douglass, J. D., Robblee, M. M., Dorfman, M. D., Stifler, D. R., Bennett, M. L., Gerritse, I., Fasnacht, R. D., Barres, B. A., Thaler, J. P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.019 · Cited by 62
Groh, J., Ribechini, E., Stadler, D., Schilling, T., Lutz, M. B., & Martini, R. (2016) · Glia · doi:10.1002/glia.22962 · Cited by 52
Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases
Bossù, P., Spalletta, G., Caltagirone, C., & Ciaramella, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00632 · Cited by 54
Gut microbes augment neurodegeneration
Erny, D., & Prinz, M. (2017) · Nature · doi:10.1038/nature21910 · Cited by 49
Self-citationDAT and TH expression marks human Parkinson’s disease in peripheral immune cells
Gopinath, A., Mackie, P. M., Hashimi, B., Buchanan, A. M., Smith, A. R., Bouchard, R. S., Shaw, G., Badov, M., Saadatpour, L., Gittis, A. H., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00333-8 · Cited by 48
Chen, C., Li, X., Ge, G., Liu, J., Biju, K. C., Laing, S. D., Qian, Y., Ballard, C., He, Z., Masliah, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23795-4 · Cited by 44
Microglia and Other Myeloid Cells in Central Nervous System Health and Disease
Gopinath, A., Collins, A., Khoshbouei, H., & Streit, W. J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265058 · Cited by 44
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
Bliederhaeuser, C., Zondler, L., Grozdanov, V., Ruf, W. P., Brenner, D., Melrose, H. L., Bauer, P., Ludolph, A. C., Gillardon, F., Kassubek, J., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0396-2 · Cited by 37
Self-citationFas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation
Krzyżowska, M., Kowalczyk, A., Skulska, K., Thörn, K., & Eriksson, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714821 · Cited by 35
CB2 expression in mouse brain: from mapping to regulation in microglia under inflammatory conditions
Grabon, W., Ruiz, A., Gasmi, N., Dégletagne, C., Georges, B., Belmeguenaï, A., Bodennec, J., Rheims, S., Marcy, G., & Bezin, L. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03202-8 · Cited by 34
CD95-ligand contributes to abdominal aortic aneurysm progression by modulating inflammation
Liu, Z., Fitzgerald, M. P., Meisinger, T. M., Batra, R., Suh, M. K., Greene, H., Penrice, A. J., Sun, L., Baxter, B. T., & Xiong, W. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy264 · Cited by 27
Sabahi, M., Joshaghanian, A., Dolatshahi, M., Jabbari, P., Rahmani, F., & Rezaei, N. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01818-6 · Cited by 26
Bal‐Price, A., Leist, M., Schildknecht, S., Monnet‐Tschudi, F., Paini, A., & Terron, A. (2018) · OECD series on adverse outcome pathways · doi:10.1787/b46c3c00-en · Cited by 28
Mice lacking Faim2 show increased cell death in the MPTP mouse model of Parkinson disease
Komnig, D., Schulz, J. B., Reich, A., & Falkenburger, B. H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13847 · Cited by 22
Human Monocytes Plasticity in Neurodegeneration
Savinetti, I., Papagna, A., & Foti, M. (2021) · Biomedicines · doi:10.3390/biomedicines9070717 · Cited by 20
Regulatable Lentiviral Hematopoietic Stem Cell Gene Therapy in a Mouse Model of Parkinson's Disease
Ge, G., Chen, C., Guderyon, M. J., Liu, J., He, Z.-X., Yu, Y., Clark, R. A., & Li, S.-L. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0030 · Cited by 15
Peng, Q., Zhang, G., Guo, X., Dai, L., Xiong, M., Zhang, Z., Chen, L., & Zhang, Z. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1046992 · Cited by 16
Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice
Pfuhlmann, K., Schriever, S. C., Legutko, B., Baumann, P., Harrison, L., Kabra, D. G., Baumgart, E. V., Tschöp, M. H., Garcia-Caceres, C., & Pfluger, P. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1076-x · Cited by 9
Xia, M., Yi, M., Guo, C., Xie, Y., Yu, W., Wang, D., & Dai, X. (2024) · Human Cell · doi:10.1007/s13577-024-01161-z · Cited by 5
HTLV-1-infected cells drive the differentiation of monocytes into macrophages in vitro
de Souza, S., Melo, G. A., Calôba, C., Campos, M. C., Pimenta, J. V., Dutra, F. F., Pereira, R. M., & Echevarria‐Lima, J. (2025) · BMC Immunology · doi:10.1186/s12865-024-00670-8 · Cited by 3
Cell-based immunotherapy for neurodegenerative disease: A promising avenue
Huerta, T. J., Urbina-Muñoz, V., Urra-Alvarez, V., Villablanca, C., Gómez‐Pérez, L. S., Saavedra, B., Contreras, T., & Vidal, R. L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00816 · Cited by 2
Microglial Biology and Physiology
Butovsky, O., Madore, C., & Weiner, H. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_13 · Cited by 2
Yung, A. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Süß, P., Hoffmann, A., Rothe, T., Baum, W., Staszewski, O., Schett, G. A., Prinz, M., Krönke, G., Glass, C. K., Winkler, J., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3263013
Self-citationImai, S. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727778494.793584717
Le récepteur CB2 et les monocytes infiltrants : des cibles thérapeutiques pendant l'épileptogenèse
Grabon, W. (2023) · theses.fr (ABES) · doi:10.70675/778cebc4zc3cbz46a7zb990z5a067c8ec7d2
Glial glucocorticoid geceptors in parkinsonism
Maatouk, L. (2015) · theses.fr (ABES) · doi:10.70675/1256b391z3e4fz471bz8360ze0eee3d095a8
Chataigner, M. (2021) · theses.fr (ABES) · doi:10.70675/a4317690zc4c8z4ba6za738zd457c6bb9b74
Horvath, M., & Imitola, J. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.579049
Metadata
- Authors
- Gao, L., Brenner, D., Llorens-Bobadilla, E., Saiz-Castro, G., Frank, T., Wieghofer, P., Hill, O., Thiemann, M., Karray, S., Prinz, M., Weishaupt, J. H., & Martin-Villalba, A.
- Affiliations
- German Cancer Research Center (DE)
- Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany 1
- Universitätsmedizin Göttingen (DE)
- University of Freiburg (DE)
- Apogenix (Germany) (DE)
- Inserm (FR)
- Universität Ulm (DE)
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2015-03-16
- Volume
- 212
- Issue
- 4
- Pages
- 469-480
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4387281
- OpenAlex
- W2135833206
- Cited by
- 42
- References
- 56
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 2 · 2018: 9 · 2017: 3 · 2016: 8 · 2015: 4
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OPUS (Augsburg University) (submittedVersion, cc-by-nc-sa)
- HAL (submittedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by-nc-sa)
- GRO (submittedVersion, cc-by-nc-sa)
- Funders
- Deutsches Krebsforschungszentrum
- Bundesministerium für Bildung und Forschung
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Fas, Fas ligand, neurodegeneration, dopaminergic neurons, MPTP-induced neurotoxicity, neuroinflammation, apoptosis, striatal dopamine, tissue-specific gene deletion
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Immunity, Innate, Inflammation, Apoptosis, Mice, Knockout, fas Receptor, Parkinsonian Disorders, Myeloid Cells, Mice, Fas Ligand Protein, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.